Amos Stemmer
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 2
- Lung Cancer Research Studies 2
-
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 6
- Co-authors
- Salomon M. Stemmer (9 shared papers)Noa Eliakim‐Raz (7 shared papers)Adva Levy‐Barda (2 shared papers)Shlomit Yust‐Katz (2 shared papers)Haim Ben‐Zvi (2 shared papers)Neta Moskovits (4 shared papers)Alexandra Benouaich‐Amiel (2 shared papers)Alona Zer (2 shared papers)
- Journals
- Cancers (3 papers)European Journal of Cancer (2 papers)JAMA Oncology (2 papers)Journal of Molecular Neuroscience (1 paper)JAMA Network Open (1 paper)
- Partner nations
- IsraelUnited StatesAustralia
In The Last Decade
Amos Stemmer
19 papers receiving 382 citations
Peers
Comparison fields: 5 of 52
- Infectious Diseases 278
- Oncology 201
- Health 60
- Modeling and Simulation 12
- Animal Science and Zoology 21
Countries citing papers authored by Amos Stemmer
This map shows the geographic impact of Amos Stemmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amos Stemmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amos Stemmer more than expected).
Fields of papers citing papers by Amos Stemmer
This network shows the impact of papers produced by Amos Stemmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amos Stemmer. The network helps show where Amos Stemmer may publish in the future.
Co-authors
The 25 scholars most cited alongside Amos Stemmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 170 | |
| 2 | 2021 | 67 | |
| 3 | 2021 | 31 | |
| 4 | 2022 | 22 | |
| 5 | 2020 | 20 | |
| 6 | 2022 | 16 | |
| 7 | 2022 | 10 | |
| 8 | 2020 | 10 | |
| 9 | 2022 | 6 | |
| 10 | 2023 | 5 | |
| 11 | 2021 | 5 | |
| 12 | 2022 | 4 | |
| 13 | 2024 | 4 | |
| 14 | 2022 | 4 | |
| 15 | 2022 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2022 | 3 | |
| 18 | 2023 | 1 | |
| 19 | 2025 | 1 |
About Amos Stemmer
Amos Stemmer is a scholar working on Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine, having authored 19 papers that have together received 387 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers), Vaccine Coverage and Hesitancy (2 papers), Colorectal and Anal Carcinomas (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Infectious Diseases (278 citations), Oncology (201 citations), Health (60 citations), Modeling and Simulation (12 citations) and Animal Science and Zoology (21 citations). Amos Stemmer has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Salomon M. Stemmer, Noa Eliakim‐Raz, Adva Levy‐Barda, Shlomit Yust‐Katz, Haim Ben‐Zvi, Neta Moskovits, Alexandra Benouaich‐Amiel, Alona Zer, Jihad Bishara and Boaz Tadmor. Their work appears in journals such as Cancers, European Journal of Cancer, JAMA Oncology, Journal of Molecular Neuroscience and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.